/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
Phenotypes of pharmacological treatment in patients with atrial fibrillation: a latent class analysis from the prospective GLORIA-AF Registry Phase III
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Registries, observational, and other studies on atrial fibrillation
Mobile health technology integrated care in atrial fibrillation patients according to atrial fibrillation subtype: a subgroup analysis of the mAFA-II randomised trial
Event: ESC Congress 2023
Topic: Clinical
Session: From mobile health technology to clinical issues in atrial fibrillation
The effect of a mobile health technology integrated care across multimorbidity patterns in atrial fibrillation patients: a latent-class ancillary analysis from the mAFA-II randomised clinical trial
Event: ESC Congress 2023
Topic: Clinical
Session: From mobile health technology to clinical issues in atrial fibrillation
Adverse outcomes according to metabolic status in obese and overweight patients with atrial fibrillation: a report from the GLORIA-AF Phase II and III Registry
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Risk factors and outcome in patients with atrial fibrillation
